Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3652003 | 0.93 | TSHR (0.53) | TSHRTDP1LMNAALDH1A1MAPK1 | |
| SCHEMBL27957193 | 0.88 | LMNA (0.60) | TSHRTDP1LMNAALDH1A1ESR1 | |
| SCHEMBL7695874 | 0.81 | TSHR (0.45) | TSHRTDP1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL3391109 | 0.79 | MAPT (0.56) | TSHRLMNAALDH1A1SMN1; SMN2MAPT | |
| SCHEMBL316833 | 0.79 | TSHR (0.53) | TSHRTDP1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL2830666 | 0.79 | HDAC3 (0.45) | TSHRTDP1L3MBTL1LMNAALDH1A1 | |
| SCHEMBL20863281 | 0.79 | L3MBTL1 (0.55) | TSHRTDP1L3MBTL1LMNAMAPK1 | |
| SCHEMBL8741712 | 0.79 | TDP1 (0.41) | TSHRTDP1LMNAALDH1A1MAPK1 | |
| SCHEMBL27899569 | 0.78 | TSHR (0.48) | TSHRTDP1LMNAALDH1A1SMN1; SMN2 | |
| SCHEMBL27720598 | 0.78 | LMNA (0.50) | TDP1LMNASMN1; SMN2MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024122747-A1 | POLYMER GEL, CONTAINING PLASTICIZER, FOR TRIBOELECTRIC ENERGY HARVESTER AND TRIBOELECTRIC ENERGY HARVESTER COMPRISING SAME | 한국기술교육대학교 산학협력단 | 2024-06-13 | — | — | WO | disclosed |
| US-20180134712-A1 | 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2018-05-17 | — | — | US | disclosed |
| US-20180134712-A1 | 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2018-05-17 | — | — | US | disclosed |
| US-9839629-B2 | Inhibitors of the renal outer medullary potassium channel | MERCK SHARP & DOHME CORP. (US) | 2017-12-12 | — | — | US | disclosed |
| US-20170291862-A1 | METHOD FOR PRODUCING OLEFIN | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-10-12 | — | — | US | disclosed |
| US-20170275298-A1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | WUXI APPTEC (SHANGHAI) CO., LTD. (CN) | 2017-09-28 | — | — | US | disclosed |
| US-20170275298-A1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | WUXI APPTEC (SHANGHAI) CO., LTD. (CN) | 2017-09-28 | — | — | US | disclosed |
| US-20160324833-A1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | MERCK SHARP & DOHME LLC | 2016-11-10 | — | — | US | disclosed |
| US-8268908-B2 | Pigment dispersion liquid, inkjet recording ink, inkjet recording method, ink cartridge and inkjet recording apparatus | CANON FINETECH INC. (JP) | 2012-09-18 | — | — | US | disclosed |
| US-8043423-B2 | Pigment dispersion liquid, ink jet recording ink, ink jet recording method, ink cartridge and ink jet recording apparatus | CANON FINETECH INC. (JP) | 2011-10-25 | — | — | US | disclosed |
| US-20100021635-A1 | PIGMENT DISPERSION LIQUID, INKJET RECORDING INK, INKJET RECORDING METHOD, INK CARTRIDGE AND INKJET RECORDING APPARATUS | CANON FINETECH INC. (JP) | 2010-01-28 | — | — | US | disclosed |
| US-7638388-B2 | Method of forming a pattern and method of manufacturing a capacitor using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-12-29 | — | — | US | disclosed |
| US-20090162552-A1 | PIGMENT DISPERSION LIQUID, INK JET RECORDING INK, INK JET RECORDING METHOD, INK CARTRIDGE AND INK JET RECORDING APPARATUS | CANON FINETECH INC. (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20080124911-A1 | METHOD OF FORMING A PATTERN AND METHOD OF MANUFACTURING A CAPACITOR USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (JP) | 2008-05-29 | — | — | US | disclosed |
| CN-101128424-A | Indole compound and use thereof | ONO PHARMACEUTICAL CO (JP) | 2008-02-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134712-A1 | 6-ALKYL DIHYDROPYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS | PDE12, PDE2A, PDE4D | TSHR 2780/4885TDP1 55/4885L3MBTL1 4517/4885 |
| US-20160324833-A1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | KCNJ11, WNK1, KCNJ1 | TSHR 1759/4885TDP1 3694/4885L3MBTL1 4260/4885 |
| US-20170275298-A1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | KCNJ11, KCNJ1, KCNJ2 | TSHR 1559/4885TDP1 3777/4885L3MBTL1 3603/4885 |
| US-20170291862-A1 | METHOD FOR PRODUCING OLEFIN | CYP4F11, CYP51A1, CYP2F1 | TSHR 3840/4885TDP1 4659/4885L3MBTL1 4531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.